Back to trial details

Intake questionnaire

A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases

Applying to MD Anderson Cancer Center · Houston, Texas

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with HER2-negative Breast Cancer Patients With Brain Metastases?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Houston for study visits?